The Office of Oncology Drug Products (OODP) is responsible for making safe and effective drug and therapeutic biologic treatments for cancer available to the U.S. public. OODP oversees development, approval, and regulation of:
Drug treatments for cancer
Therapeutic biologic treatments for cancer
Therapies for prevention of cancer
Drug and biologic products used for medical imaging
Products for treatment of nonmalignant hematologic conditions
